TrialThe European respiratory journal2025

Cathepsin C (dipeptidyl peptidase 1) inhibition in adults with bronchiectasis: AIRLEAF, a phase II randomised, double-blind, placebo-controlled, dose-finding study.

James D Chalmers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.